Skip to main content

DES

Original Contribution
06/01/2022
The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...
The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...
The application of 2 distinct...
06/01/2022
Journal of Invasive Cardiology
Original Contribution
03/30/2018
The aim of our study was to evaluate the safety, feasibility, and cost effectiveness of a 48 mm everolimus-eluting stent (EES) during treatment of very long coronary lesions.
The aim of our study was to evaluate the safety, feasibility, and cost effectiveness of a 48 mm everolimus-eluting stent (EES) during treatment of very long coronary lesions.
The aim of our study was to...
03/30/2018
Journal of Invasive Cardiology
Original Contribution
11/15/2016
The results of this large meta-analysis suggest that patients with DES (n = 39,213) in comparison with BMS implantation (n = 26,461) for PCI to SVG lesions had lower MACE, all-cause mortality, and TVR rates, without a significant reduction in...
The results of this large meta-analysis suggest that patients with DES (n = 39,213) in comparison with BMS implantation (n = 26,461) for PCI to SVG lesions had lower MACE, all-cause mortality, and TVR rates, without a significant reduction in...
The results of this large...
11/15/2016
Journal of Invasive Cardiology